| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |